Biogen (NASDAQ:BIIB) announced its Q4 earnings on Friday, February 6, 2026 at 07:00 AM.

Here’s a breakdown of the earnings report.

Earnings

Biogen beat estimated earnings by 22.84%, reporting an EPS of $1.99 versus an estimate of $1.62.

Revenue was down $176.00 million from the same period last year.

Overview of Past Earnings

The company beat on EPS by $0.92 …

Full story available on Benzinga.com